Investigational Site Number : 4040001

Nairobi 00202

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, RSV Immunisation

Studies at this site

• Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older — Stopped early
• Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers — Stopped early